We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ICU Medical Inc | NASDAQ:ICUI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.43 | 0.24% | 180.94 | 172.77 | 290.06 | 183.98 | 179.125 | 180.61 | 178,457 | 01:00:00 |
Wells Fargo 2024 Healthcare Conference on September 4, 2024
Vivek Jain, Chief Executive Officer, will attend one-on-one meetings at the Wells Fargo 2024 Healthcare Conference in Boston on Wednesday, September 4, 2024.
Morgan Stanley 22nd Annual Global Healthcare Conference on September 6, 2024
Vivek Jain, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Friday, September 6, 2024. The discussion will begin at 4:00 a.m. PT (7:00 a.m. ET) and will be webcast live on the Event Calendar section of the Company’s Investor Relations website at https://ir.icumed.com. A replay of the webcast will be archived on the website for future viewing. Company management will also participate in one-on-one meetings at the conference.
About ICU Medical
ICU Medical (Nasdaq:ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com
CONTACT:ICU MedicalBrian Bonnell, Chief Financial Officer(949) 366-2183
ICR, Inc.John Mills, Managing Partner(646) 277-1254
Source: ICU Medical, Inc.
1 Year ICU Medical Chart |
1 Month ICU Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions